Subscribe To
Nano one materials successfully completes phase two of co-development project with cbmm
Nano One Materials Corp (TSX:NANO, OTC:NNOMF) said phase two of the advanced lithium-ion battery cath...
May 17, 2023, 8:16 am
Tscan therapeutics presents preliminary phase 1 clinical results on tsc-100 and tsc-101 at the american society of gene & cell therapy 26th annual meeting
Poster highlights phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell...
May 17, 2023, 7:00 am
3 penny stocks primed to be 10-baggers in 5 years
In the entire history of financial markets, equities have never failed to make a strong comeback after a disappointing phase. Be it the Great Depressi...
May 17, 2023, 6:35 am
Oxford cannabinoid rise continues as first clincial trial gets started
Oxford Cannabinoid rose again as its confirmed recruitment for a phase 1 trial of its lead pain relief ...
May 17, 2023, 3:58 am
Oxford cannabinoid to start phase 1 trial for pain relief drug
Oxford Cannabinoid Technologies has received approval for a phase 1 trial in the UK of its lead pain r...
May 17, 2023, 2:45 am
Audusd analysis – may 17, 2023
The AUDUSD pair has been moving within a relatively tight range, oscillating between 0.6635 and 0.6709. This consolidation ...
May 17, 2023, 1:41 am
Enphase: fortune favors the brave now
Enphase Energy investors endured a 26% drop in its stock price after releasing weak Q2 guidance, wiping...
May 16, 2023, 12:00 pm
Nftfi launches earn season 1: promoting responsible nft lending
NFTfi, a leading NFT lending platform, has launched the next phase of its loyalty program NFTfi Rewards...
May 16, 2023, 8:09 am
Gold seen in consolidation phase
Gold is bullish on higher time frame charts where we expect a break to new ATH high, but ideally, this will occur after the current complex correction...
May 16, 2023, 7:10 am
Audusd analysis – may 16, 2023
The AUDUSD pair has been entrenched in a downtrend since its peak at 0.6817, with the recent bounce from 0.6635 being viewed as a corrective consolida...
May 16, 2023, 3:38 am
Perspective therapeutics reports first quarter fiscal 2023 results
Additional CDMO capabilities added to increase availability of clinical trial product in the US phase I...
May 16, 2023, 12:22 am
Bellerophon provides clinical program update and reports first quarter 2023 financial results
Last Patient Completed Blinded Treatment in REBUILD phase 3 Trial for INOpulse®; Pivotal Top-line Data...
May 15, 2023, 8:50 pm
Tesla: revisiting my 13 reasons to be cautious
Tesla, Inc. is in a strange position of a $500 billion empire finding itself in the growing pain phase. Tesla stock has fallen about 14% since my last...
May 15, 2023, 3:17 pm
Terns pharmaceuticals reports first quarter 2023 financial results and corporate updates
– Top-line data from phase 2a DUET clinical trial of TERN-501 (THR-β agonist) in NASH expected in th...
May 15, 2023, 12:05 pm
Pds biotech provides business update and reports first quarter 2023 financial results
Updated data from VERSATILE-002 phase 2 trial to be presented at ASCO 2023 Company to host conference c...
May 15, 2023, 11:30 am
Bridgebio pharma to present updated data from its bbp-812 canavan disease gene therapy program at the 2023 american society of gene and cell therapy (asgct) annual meeting
PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage ...
May 15, 2023, 11:30 am
S&p 500 bear market: the smartest investors are buying these 3 beaten-down stocks
Despite Enphase Energy's recent setbacks, its fundamentals remain solid. 3M is in the bargain-bin with ...
May 15, 2023, 9:53 am
Us 500 index extends sideways move
The US 500 stock index (cash) has been gaining ground since mid-March, slicing through both its 50 and 200-day simple moving averages (SMAs). Neverthe...
May 15, 2023, 8:49 am
Bridgebio pharma to present updated data from its bbp-812 canavan disease gene therapy program at the 2023 american society of gene and cell therapy (asgct) annual meeting
PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage ...
May 15, 2023, 7:30 am
Ecb de guindos indicates final phase of monetary policy tightening
In an interview with Il Sole 24 Ore, ECB Vice President Luis de Guindos highlighted the central bank’s shift towards a more conventional monetary po...
May 15, 2023, 3:12 am